WHO scientists …..on Friday, the Delta version of COVID-19, which has been first identified in India, is now the world-wide dominant disease variant.
In a trial to meet the efficacy standard, Soumya Swaminathan was also disappointed at the failure of the CureVac candidate, particularly because highly transmissible versions stimulate the requirement for new and effective shots.
Britain has reported a steep increase in Delta infection, while the leading public health official in Germany predicted that, despite increasing vaccination rates, it would quickly become the dominant version of the country.
In COVID-19, the Kremlin has accused the new delta variant most of the new vaccination and nihilism in Moscow of a reluctance to have a third wave. “Due to its increased transmissibility, the Delta variant is well on track to become the dominant variety globally,” said Swaminathan at a press conference.
CureVac mentioned Coronavirus variants when this week the German company reported that their vaccine only proved 47 percent efficient in disease prevention, timid of the 50% benchmark of the WHO.
In its study population, the company stated that it documents at least 13 variants. Because Pfizer and BioNTech and Moderna have also had similar mRNE vaccines with efficacy rates of more than 90%, Swaminathan stated that the world expects CureVac candidate to receive more.
“Of all mRNA vaccines we are unable to assume because they are slightly different, just because they are another mRNA vaccine,” Swaminathan said, adding that the surprise failure underscored the value of robust clinical tests for the testing of new products.
Officials of the WHO stated that Africa remains a priority although it represents only approximately 5% of new global infections and 2% of deaths.
The WHO Emergency Program head Mike Ryan said that in the last week, new cases have doubled in Namibia, Sierra Leone, Liberia and Rwanda, while accessing vaccine remains tiny.
“This is a very, very worrisome trajectory,” said Ryan. “The brutal truth is that we have left huge sections of people, the vulnerable population of Africa, unprotected by vaccines at a time of many variants with increased transmissibility.”
